Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Cost of Revenue (2021 - 2025)

Core Scientific's Cost of Revenue history spans 5 years, with the latest figure at $59.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 120.38% year-over-year to $59.0 million; the TTM value through Dec 2025 reached $281.1 million, up 2719.95%, while the annual FY2025 figure was $281.1 million, 2719.95% up from the prior year.
  • Cost of Revenue for Q4 2025 was $59.0 million at Core Scientific, down from $77.2 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $620.2 million in Q4 2022 and bottomed at -$289.5 million in Q4 2024.
  • The 5-year median for Cost of Revenue is $72.5 million (2025), against an average of $86.4 million.
  • The largest annual shift saw Cost of Revenue soared 22843.07% in 2022 before it crashed 200.88% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $303.4 million in 2021, then surged by 104.41% to $620.2 million in 2022, then crashed by 53.74% to $286.9 million in 2023, then plummeted by 200.88% to -$289.5 million in 2024, then skyrocketed by 120.38% to $59.0 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Cost of Revenue are $59.0 million (Q4 2025), $77.2 million (Q3 2025), and $73.6 million (Q2 2025).